146 related articles for article (PubMed ID: 22385789)
1. Non-necrotizing autoimmune myopathy with pipestem type capillaries - a light and electron microscopic study.
Janzen RW; Weber M; Schlote W
Clin Neuropathol; 2012; 31(2):81-6. PubMed ID: 22385789
[TBL] [Abstract][Full Text] [Related]
2. Pipestem capillaries in necrotizing myopathy revisited.
Schröder NW; Goebel HH; Brandis A; Ladhoff AM; Heppner FL; Stenzel W
Neuromuscul Disord; 2013 Jan; 23(1):66-74. PubMed ID: 23102899
[TBL] [Abstract][Full Text] [Related]
3. Necrotizing myopathy with microvascular deposition of the complement membrane attack complex.
De Bleecker J; Vervaet V; Van den Bergh P
Clin Neuropathol; 2004; 23(2):76-9. PubMed ID: 15074581
[TBL] [Abstract][Full Text] [Related]
4. Necrotizing myopathy with pipestem capillaries and minimal cellular infiltration: a case associated with cutaneous signs of dermatomyositis.
Authier FJ; Kondo H; Ghnassia RT; Revuz J; Gherardi RK
Neurology; 1996 May; 46(5):1448-51. PubMed ID: 8628498
[TBL] [Abstract][Full Text] [Related]
5. An unusual case of inflammatory necrotizing myopathy and neuropathy with pipestem capillaries.
Patil AK; Prabhakar AT; Sivadasan A; Alexander M; Chacko G
Neurol India; 2015; 63(1):72-6. PubMed ID: 25751473
[TBL] [Abstract][Full Text] [Related]
6. The geoepidemiology of autoimmune muscle disease.
Prieto S; Grau JM
Autoimmun Rev; 2010 Mar; 9(5):A330-4. PubMed ID: 19906360
[TBL] [Abstract][Full Text] [Related]
7. Autophagy markers LC3 and p62 accumulate in immune-mediated necrotizing myopathy.
Girolamo F; Lia A; Annese T; Giannini M; Amati A; D'Abbicco D; Tampoia M; Virgintino D; Ribatti D; Serlenga L; Iannone F; Trojano M
Muscle Nerve; 2019 Sep; 60(3):315-327. PubMed ID: 31172530
[TBL] [Abstract][Full Text] [Related]
8. Statin-associated necrotizing autoimmune myopathy.
Fernandes GH; Zanoteli E; Shinjo SK
Mod Rheumatol; 2014 Sep; 24(5):862-4. PubMed ID: 24517559
[TBL] [Abstract][Full Text] [Related]
9. Necrotizing myopathy with pipestem capillaries, microvascular deposition of the complement membrane attack complex (MAC), and minimal cellular infiltration.
Emslie-Smith AM; Engel AG
Neurology; 1991 Jun; 41(6):936-9. PubMed ID: 2046947
[TBL] [Abstract][Full Text] [Related]
10. Skeletal muscle vasculitis exclusive of inflammatory myopathic conditions: a clinicopathologic study of 40 patients.
Prayson RA
Hum Pathol; 2002 Oct; 33(10):989-95. PubMed ID: 12395371
[TBL] [Abstract][Full Text] [Related]
11. Polymyositis: an overdiagnosed entity.
van der Meulen MF; Bronner IM; Hoogendijk JE; Burger H; van Venrooij WJ; Voskuyl AE; Dinant HJ; Linssen WH; Wokke JH; de Visser M
Neurology; 2003 Aug; 61(3):316-21. PubMed ID: 12913190
[TBL] [Abstract][Full Text] [Related]
12. Pathogenic aspects of dermatomyositis, polymyositis and overlap myositis.
Gherardi RK
Presse Med; 2011 Apr; 40(4 Pt 2):e209-18. PubMed ID: 21376512
[TBL] [Abstract][Full Text] [Related]
13. Automated image-analysis method for the quantification of fiber morphometry and fiber type population in human skeletal muscle.
Reyes-Fernandez PC; Periou B; Decrouy X; Relaix F; Authier FJ
Skelet Muscle; 2019 May; 9(1):15. PubMed ID: 31133066
[TBL] [Abstract][Full Text] [Related]
14. Nuclear actin aggregation is a hallmark of anti-synthetase syndrome-induced dysimmune myopathy.
Stenzel W; Preuße C; Allenbach Y; Pehl D; Junckerstorff R; Heppner FL; Nolte K; Aronica E; Kana V; Rushing E; Schneider U; Claeys KG; Benveniste O; Weis J; Goebel HH
Neurology; 2015 Mar; 84(13):1346-54. PubMed ID: 25746564
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory myopathies: evaluation and management.
Greenberg SA
Semin Neurol; 2008 Apr; 28(2):241-9. PubMed ID: 18351525
[TBL] [Abstract][Full Text] [Related]
16. Immune Mediated Necrotizing Myopathy: Where do we Stand?
Mohammed AGA; Gcelu A; Moosajee F; Botha S; Kalla AA
Curr Rheumatol Rev; 2019; 15(1):23-26. PubMed ID: 29623846
[TBL] [Abstract][Full Text] [Related]
17. Polymyositis, dermatomyositis, and autoimmune necrotizing myopathy: clinical features.
Khan S; Christopher-Stine L
Rheum Dis Clin North Am; 2011 May; 37(2):143-58, v. PubMed ID: 21444016
[TBL] [Abstract][Full Text] [Related]
18. Myopathy and neuropathy with pipestem capillaries and vascular activated complement deposition.
Reimann J; Kornblum C; Tolksdorf K; Brück W; van Landeghem FK
Neurology; 2011 Jul; 77(4):401-3. PubMed ID: 21753180
[No Abstract] [Full Text] [Related]
19. Necrotizing myopathies: beyond statins.
Mammen AL
Curr Opin Rheumatol; 2014 Nov; 26(6):679-83. PubMed ID: 25203117
[TBL] [Abstract][Full Text] [Related]
20. Immune-mediated necrotizing myopathy is characterized by a specific Th1-M1 polarized immune profile.
Preuße C; Goebel HH; Held J; Wengert O; Scheibe F; Irlbacher K; Koch A; Heppner FL; Stenzel W
Am J Pathol; 2012 Dec; 181(6):2161-71. PubMed ID: 23058368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
